Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Neuropsychiatric Sequelae of Carbon Monoxide Poisoning Clinical Trial

Official title:

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00596180
• Other study ID #: LSU IRB #6626
• Status: Recruiting
• Phase: N/A
• First received: January 4, 2008
• Last updated: April 16, 2017
• Start date: January 2007
• Est. completion date: December 2019

Study information

• Verified date: April 2017
• Source: Louisiana State University Health Sciences Center in New Orleans
• Contact: Paul G Harch, M.D.
• Phone: 504-309-4948
• Email: paulharchmd[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Description:

The study is a retrospective review of the PI's experience using SPECT brain imaging and hyperbaric oxygen therapy in the diagnosis and treatment of non-acute phases of carbon monoxide poisoning. The purpose is to see if the SPECT brain imaging is consistent with the clinical condition and cognitive testing on the patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: December 2019
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment

Exclusion Criteria:

Related Conditions & MeSH terms

• Carbon Monoxide Poisoning
• Neuropsychiatric Sequelae of Carbon Monoxide Poisoning
• Poisoning

Intervention

Drug:
• HBOT
total body exposure to greater than atmospheric pressure oxygen

Locations

Country	Name	City	State
United States	Family Physicians Center	Marrero	Louisiana

Sponsors (2)

Lead Sponsor	Collaborator
Paul G. Harch, M.D.	Harch Hyperbaric Research Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	SPECT brain imaging		after completion of HBOT
Secondary	clinical history and physical exam		after completion of HBOT
Secondary	Neuropsychological testing	Neuropsychological testing performed after the final HBOT in those who had neuropsychological testing before HBOT	After the final HBOT